O14965 (AURKA_HUMAN) Homo sapiens (Human)
Aurora kinase A UniProtKBInterProSTRINGInteractive Modelling
403 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
186 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Structure of Aurora Kinase A in complex with activator peptide |
Heteromer Q8TEP8; | 100.0 | 3×ADP; | |||
| Aurora-A kinase domain in complex with vNAR-D01 (crystal form 2) |
Heteromer Q8JJ25; | 99.62 | 1×ADP; 2×SO4; 10×EDO; | |||
| Aurora-A in complex with TACC3 |
Heteromer Q9Y6A5; | 99.22 | 1×ADP; 3×GOL; 4×SO4; | |||
| Crystal structure of Aurora-A bound to a hydrocarbon-stapled proteomimetic of TPX2 |
Heteromer Q9ULW0; | 99.62 | 1×ADP; 1×PG4; 1×SO4; 2×PEG; 1×MES; 1×P4G; 1×CL; 2×MG; | |||
| Aurora-A kinase domain in complex with vNAR-D01 S93R |
Heteromer Q8JJ25; | 100.0 | 1×ADP; 2×EDO; 2×PEG; | |||
| Structure of Aurora-A 122-403, phosphorylated on Thr287, Thr288 and bound to TPX2 1-43 |
Heteromer Q9ULW0; | 100 | 1×ADP; 3×MG; 3×SO4; | |||
| Structure of dephosphorylated Aurora A (122-403) bound to TPX2 and AMPPCP |
Heteromer Q9ULW0; | 100 | 2×ACP; 1×SO4; | |||
| Aurora-A in complex with CEP192 and an inhibitory monobody |
Heteromer Q8TEP8; | 97.63 | 2×ADP; 1×GOL; 1×MG; | |||
| Structure Aurora A (122-403) bound to activating monobody Mb1 and AMPPCP |
Heteromer | 100 | 1×ACP; 1×MG; 4×SO4; | |||
| Crystal structure of Aurora A in complex with VX-680 and TPX2 |
Heteromer Q9ULW0; | 100 | 1×VX6; 1×SO4; | |||
| Aurora-A kinase domain in complex with vNAR-D01 (crystal form 1) |
Heteromer Q8JJ25; | 99.62 | 1×ADP; 7×SO4; 5×EDO; | |||
| Crystal structure of Aurora-A kinase in complex with N-Myc |
Heteromer P04198; | 99.62 | 1×ADP; 2×MG; | |||
| Crystal structure of a covalently linked Aurora-A N-Myc complex |
Heteromer P04198; | 99.24 | 1×ADP; 2×MG; 3×GOL; 1×BCN; 1×NA; 1×JWG; | |||
| Crystal structure of aurora A in complex with TPX2 and compound 10 |
Heteromer Q9ULW0; | 100 | 2×2JZ; | |||
| AurA bound to danusertib and activating monobody Mb1 |
Heteromer | 100 | 5×EDO; 2×SO4; 1×MES; 1×PO4; 1×PDO; 1×627; | |||
| AurA bound to danusertib and inhibiting monobody Mb2 |
Heteromer | 100.0 | 1×EDO; 2×ACT; 1×627; | |||
| Structure of Aurora A (122-403) bound to inhibitory Monobody Mb2 and AMPPCP |
Heteromer | 100.0 | 2×ACP; | |||
| Structure of dephosphorylated Aurora A (122-403) in complex with inhibiting monobody and AT9283 in … |
Heteromer | 100.0 | 2×35R; | |||
| Aurora A Kinase Apo | homo-4-mer | 99.62 | ||||
| TPX2 residues 7-20 fused to Aurora A residues 116-389 C247V + D256N + C319V triple mutant disulfide… | homo-2-mer | 100 | 2×ANP; 4×MG; 2×MLA; | |||
| TPX2 residues 7-20 fused to Aurora A residues 116-389 C247V + C319V double mutant dephosphorylated,… | homo-2-mer | 100 | 2×GLC; 2×ANP; | |||
| TPX2 residues 7-20 fused to Aurora A residues 116-389 with C290 disulfide bonded to compound 8-34, … | homo-2-mer | 100.0 | 2×MG; 2×AMP; 2×R74; 2×MLA; | |||
| TPX2 residues 7-20 fused to Aurora A residues 116-389 with C290 disulfide bonded to compound 7-80, … | homo-2-mer | 100.0 | 4×MG; 2×ANP; 2×MLA; 2×R7D; 1×GOL; | |||
| TPX2 residues 7-20 fused to Aurora A residues 116-389 modified with cacodylate and in complex with … | homo-2-mer | 100.0 | 4×CL; 2×DTD; 2×ANP; 8×GOL; | |||
| Crystal structure of Aurora A 122-403 C290A, N332A, Q335A, C393A bound to ADP | homo-2-mer | 98.87 | 2×ADP; 2×EPE; 4×GOL; 2×MPO; 2×NO3; 6×MG; | |||
| Aurora A in complex with a bisanilinopyrimidine | homo-2-mer | 100.0 | 2×48B; 8×SO4; | |||
| Aurora A ligand complex | homo-2-mer | 100.0 | 6×SO4; 2×EG7; | |||
| Aurora A ligand complex | homo-2-mer | 100.0 | 2×EGJ; 2×DMS; 2×SO4; | |||
| AURORA KINASE A IN COMPLEX WITH THE AUR-A/PDK1 INHIBITOR VI8 | monomer | 100.0 | 1×V0K; | |||
| TPX2 residues 7-20 fused to Aurora A residues 116-389 in complex with AMP-PNP | monomer | 100.0 | 1×ANP; 1×GOL; 2×CL; 1×MG; | |||
| Aurora A in complex with ADP | monomer | 99.63 | 2×MG; 1×ADP; | |||
| Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis for potency and sp… | monomer | 100.0 | 1×MMH; | |||
| Identification, SAR Studies and X-ray Cocrystal Analysis of a Novel Furano-pyrimidine Aurora Kinase… | monomer | 100.0 | 1×PFQ; | |||
| Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | monomer | 99.63 | 1×ADP; 2×MG; 1×A8K; 3×CL; | |||
| SAR156497 an exquisitely selective inhibitor of Aurora kinases | monomer | 100.0 | 1×JVE; | |||
| Aurora A inhibitor complex | monomer | 98.88 | 1×97B; | |||
| Aurora-2 T287D T288D complexed with PHA-680632 | monomer | 100.0 | 1×MPY; | |||
| Crystal structure of Aurora A in complex with 7-(2-Anilinopyrimidin-4-yl)-1-benzazepin-2-one deriva… | monomer | 100.0 | 1×S9K; | |||
| SAR156497 an exquisitely selective inhibitor of Aurora kinases | monomer | 100.0 | 1×Y3M; | |||
| Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | monomer | 99.62 | 1×ADP; 2×MG; 1×A9B; 3×CL; | |||
| Crystal Structure of Aurora2 kinase in complex with a GSK3beta inhibitor | monomer | 100.0 | 1×OFI; | |||
| Crystal structure of Aurora-A L210C catalytic domain in complex with ASDO6 ligand | monomer | 99.22 | 1×G7T; 3×CL; 3×ACT; 1×PGF; | |||
| Crystal structures of human kinase Aurora A | monomer | 99.61 | 1×ADN; | |||
| Aurora A in complex with YL1-038-31 | monomer | 99.62 | 1×0BX; | |||
| Aurora A in complex with CD532 | monomer | 99.62 | 1×CJ5; 1×MG; 1×PO4; 2×DMS; 1×EDO; | |||
| Crystal structure of Aurora A (STK6) in complex with macrocycle ODS2003208 | monomer | 100.0 | 2×CIT; 5×EDO; 1×Q7Q; | |||
| Novel Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetocho… | monomer | 100.0 | 1×VX6; | |||
| Aurora A in complex with RPM1686 | monomer | 99.62 | 1×0C8; 2×EDO; | |||
| Aurora A in complex with YL1-038-18 | monomer | 99.62 | 3×EDO; 1×NHI; | |||
| Aurora A in complex with RPM1680 | monomer | 99.62 | 1×0C0; 3×EDO; | |||
| Novel Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetocho… | monomer | 99.62 | 1×WPH; | |||
| Complex of Aurora-A bound to an Imidazopyridine-based inhibitor | monomer | 100.0 | 1×VEK; 4×SO4; | |||
| Crystal structures of human kinase Aurora A | monomer | 100.0 | 1×ADN; | |||
| Aurora A in complex with RPM1693 | monomer | 99.62 | 1×0C3; 1×EDO; 1×PEG; | |||
| Crystal structures of human kinase Aurora A | monomer | 99.61 | 1×ADN; | |||
| Crystal Structure of Aurora A Kinase complexed with inhibitor | monomer | 100.0 | 1×AKI; | |||
| Crystal structure of Aurora A in complex with 7-(2-Anilinopyrimidin-4-yl)-1-benzazepin-2-one deriva… | monomer | 100.0 | 1×S9H; | |||
| Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | monomer | 99.62 | 1×ADP; 2×MG; 3×CL; 1×A4W; | |||
| Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | monomer | 99.62 | 1×ADP; 2×MG; 1×A6Z; | |||
| Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | monomer | 99.62 | 1×ADP; 2×MG; 1×A7N; | |||
| Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | monomer | 99.62 | 1×ADP; 2×MG; 2×CL; 1×A65; | |||
| Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | monomer | 99.62 | 1×ADP; 2×MG; 1×A8H; 1×SO4; | |||
| Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | monomer | 99.62 | 1×ADP; 2×MG; 1×A6H; | |||
| Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | monomer | 99.62 | 1×ADP; 2×MG; 1×A9E; | |||
| Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | monomer | 99.62 | 1×ADP; 2×MG; 1×A98; | |||
| Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | monomer | 99.62 | 1×ADP; 2×MG; 3×CL; 1×A7H; | |||
| Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | monomer | 99.62 | 1×ADP; 2×MG; 3×CL; 1×A6W; | |||
| Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | monomer | 99.62 | 1×ADP; 2×MG; 1×A7K; | |||
| Aurora-A in complex with shape-diverse fragment 55 | monomer | 99.62 | 1×ADP; 2×GOL; 2×MG; 4×CL; 1×JRT; | |||
| Aurora A Kinase in complex with ATP in space group P41212 | monomer | 100 | 2×MG; 1×SO4; 1×ATP; | |||
| Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | monomer | 99.62 | 1×ADP; 2×MG; 1×A5W; | |||
| Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | monomer | 99.62 | 1×ADP; 2×MG; 3×CL; 1×AY4; | |||
| Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | monomer | 99.62 | 1×ADP; 2×MG; 1×A6E; | |||
| Aurora-A in complex with shape-diverse fragment 58 | monomer | 99.62 | 1×ADP; 2×MG; 1×CL; 1×JRW; | |||
| Aurora-A in complex with shape-diverse fragment 57 | monomer | 99.62 | 1×ADP; 2×MG; 3×CL; 1×JRQ; | |||
| Aurora A in complex with ATP and AA35. | monomer | 100 | 1×MG; 1×5DN; 1×SO4; 1×ATP; | |||
| Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | monomer | 99.62 | 1×ADP; 2×MG; 1×A5Q; 2×CL; | |||
| Crystal structure of Aurora A 122-403 C290A, C393A bound to ADP | monomer | 99.62 | 1×ADP; 2×GOL; 2×MG; 4×CL; | |||
| Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | monomer | 99.62 | 1×ADP; 2×MG; 1×A5H; | |||
| Aurora-A in complex with shape-diverse fragment 56 | monomer | 99.62 | 1×ADP; 2×MG; 4×CL; 1×JSN; | |||
| Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | monomer | 99.62 | 1×ADP; 2×MG; 1×A5K; | |||
| Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | monomer | 99.62 | 1×ADP; 2×MG; 1×A5E; | |||
| Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | monomer | 99.62 | 1×ADP; 2×MG; 1×A7Q; | |||
| Aurora A kinase activated mutant (T287D) in complex with ADPNP | monomer | 100.0 | 1×GOL; 1×PO4; 1×ANP; | |||
| Aurora-A in complex with shape-diverse fragment 39 | monomer | 100.0 | 1×ADP; 2×MG; 1×JSB; | |||
| Structure of dephosphorylated Aurora A (122-403) bound to AMPPCP in an active conformation | monomer | 100.0 | 1×ACP; 1×MG; | |||
| Reversible lysine-targeted probes reveal residence time-based kinase selectivity in vivo | monomer | 99.61 | 1×5YZ; 3×CL; | |||
| Aurora-A Inhibitor Structure | monomer | 98.87 | 1×ZZL; 1×EDO; 2×ACT; 1×DMS; | |||
| Crystal Structure of Aurora-A L210C catalytic domain in complex with ASDO2 | monomer | 99.22 | 1×G7W; 1×SO4; 1×CL; | |||
| Novel Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetocho… | monomer | 100.0 | 1×YPH; | |||
| Aurora-A kinase domain in complex with Coenzyme A | monomer | 100 | 1×COA; 4×MG; 3×PEG; | |||
| Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment | monomer | 99.62 | 1×ADP; 2×MG; 2×CL; 1×A5Z; | |||
| Crystal structure of Aurora-A in complex with FMF-03-145-1 (compound 2) | monomer | 100.0 | 1×9YQ; | |||
| Aurora A kinase in complex with 2-(3-chloro-5-fluorophenyl)quinoline-4-carboxylic acid and JNJ-7706… | monomer | 100.0 | 1×9QT; 1×SKE; 1×MG; | |||
| Crystal Structure of Aurora Kinase A in complex with BENZO[C][1,8]NAPHTHYRIDIN-6(5H)-ONE | monomer | 100 | 1×XU1; | |||
| Aurora A in complex with YL5-81-1 | monomer | 99.62 | 1×0C6; | |||
| Aurora A in complex with YL1-038-21 | monomer | 99.62 | 1×NHU; 3×EDO; | |||
| Crystal Structure of Aurora Kinase A in complex with N-{4-[(6-oxo-5,6-dihydrobenzo[c][1,8]naphthyri… | monomer | 100.0 | 1×XU2; | |||
| Aurora A kinase in complex with TPX2-inhibitor 9 | monomer | 100 | 3×MG; 1×SO4; 6×CL; 4×DMS; 2×ACT; 1×ADP; 1×T5L; 5×GOL; 1×T0L; | |||
| Structure of Aurora-2 in complex with PHA-680626 | monomer | 100 | 1×626; 2×ARS; | |||
| Aurora A Kinase in Complex with ATP in Space Group P6122 | monomer | 100.0 | 1×MG; 1×ATP; | |||
| Aurora A Kinase in Complex with JNJ-7706621 in Space Group P6122 | monomer | 100.0 | 1×SKE; | |||
| Crystal Structure of Aurora A Kinase Domain Bound to MK-5108 | monomer | 100.0 | 1×5VC; | |||
| Aurora A Kinase in Complex with ATP in Space Group P6122 | monomer | 100 | 1×MG; 1×SO4; 1×ATP; | |||
| Aurora A Kinase in Complex with AA29 and JNJ-7706621 in Space Group P6122 | monomer | 100.0 | 1×SKE; 1×5E2; | |||
| Aurora-A kinase complexed with AMPPNP | monomer | 100.0 | 1×SO4; 1×ANP; | |||
| Aurora A Kinase in Complex with AA30 and JNJ-7706621 in Space Group P6122 | monomer | 100.0 | 1×5E1; 1×SKE; | |||
| Human AURKA bound to BRD-7880 | monomer | 100.0 | 1×F8Z; | |||
| Structure of Aurora-A bound to a selective imidazopyrazine inhibitor | monomer | 100.0 | 1×A0H; | |||
| Structure of Human Aurora-A 122-403 phosphorylated on Thr287, Thr288 | monomer | 100 | 1×ADP; 2×MG; | |||
| Aurora A kinase domain with compound 2 (N-[1-(3-cyanobenzyl)-1H-pyrazol-4-yl]-6-(1H-pyrazol-4-yl)-1… | monomer | 98.41 | 1×2VU; | |||
| Aurora A in complex with RPM1722 | monomer | 99.62 | 1×0C4; 3×EDO; | |||
| Aurora A in complex with YL5-083 | monomer | 99.62 | 1×0BY; 2×EDO; | |||
| Aurora A Kinase in Complex with AA35 and ATP in Space Group P6122 | monomer | 100.0 | 1×MG; 1×5DN; 1×ATP; | |||
| AURORA-A T288E COMPLEXED WITH PHA-828300 | monomer | 100.0 | 1×400; | |||
| Design, synthesis, and biological evaluation of pyrazolopyridine-sulfonamides as potent multiple-mi… | monomer | 100.0 | 1×D37; | |||
| Aurora A kinase in complex with 2-(3-fluorophenyl)quinoline-4-carboxylic acid and ATP | monomer | 100.0 | 2×MG; 1×SO4; 1×ATP; 1×9QK; | |||
| Aurora A Kinase in Complex with AA35 and ATP in Space Group P6122 | monomer | 100.0 | 1×MG; 1×5DN; 1×ATP; | |||
| Aurora A in complex with RK2-17-01 | monomer | 99.62 | 1×NHJ; 2×EDO; | |||
| Aurora A in complex with YL1-038-09 | monomer | 99.62 | 1×0C9; | |||
| Crystal Structure of Aurora-A Protein Kinase | monomer | 100.0 | 2×MG; 1×PO4; 1×ADP; | |||
| Aurora A kinase in complex with TPX2-inhibitor 6 | monomer | 100.0 | 1×ADP; 2×MG; 5×GOL; 1×T5L; 6×SO4; 1×DMS; 1×T2O; | |||
| Crystal structure of benzamide 9 bound to AuroraA | monomer | 100.0 | 1×LJE; | |||
| Aurora A kinase activated mutant (T287D) in complex with a 5- aminopyrimidinyl quinazoline inhibitor | monomer | 100.0 | 1×HPM; | |||
| Aurora A Kinase in Complex with AA35 and JNJ-7706621 in Space Group P6122 | monomer | 100.0 | 1×5DN; 1×SKE; | |||
| Structure of AuroraA with pyridyl-pyrimidine urea inhibitor | monomer | 100.0 | 1×AK8; 1×SO4; | |||
| Aurora A in complex with SO2-162 | monomer | 99.62 | 1×0C7; 5×EDO; | |||
| Aurora A Kinase complexed with SCH 1473759 | monomer | 100.0 | 1×PG4; 1×EML; | |||
| Aurora A kinase in complex with TPX2-inhibitor 3 | monomer | 100.0 | 1×ADP; 2×MG; 1×T4C; 1×T5L; 6×SO4; 2×DMS; 1×ACT; | |||
| Structure of apo, dephosphorylated Aurora A (122-403) in an active conformation | monomer | 100.0 | 1×P4G; | |||
| Aurora A Kinase in Complex with AA30 and ATP in Space Group P6122 | monomer | 99.62 | 1×5E1; 1×MG; 1×ATP; | |||
| Crystal structure of V174M mutant of Aurora-A kinase | monomer | 99.62 | 1×ADP; 2×CA; | |||
| Structure of Aurora kinase A complexed to benzoimidazole-indazole inhibitor XIII | monomer | 100.0 | 1×N13; | |||
| Aurora A kinase bound to a highly selective imidazopyridine inhibitor | monomer | 100.0 | 1×FH3; | |||
| Aurora kinase A complexed to pyrazole aminoquinoline I | monomer | 99.24 | 1×RO9; | |||
| Structure determination of Aurora Kinase in complex with inhibitor | monomer | 100.0 | 1×L0G; | |||
| Aurora A kinase bound to a highly selective imidazopyridine inhibitor | monomer | 100.0 | 1×FH5; | |||
| Aurora A kinase bound to an imidazopyridine inhibitor (14a) | monomer | 100.0 | 1×NL4; | |||
| Aurora-A bound to an inhibitor | monomer | 100.0 | 2×SO4; 1×X6D; | |||
| Aurora A in Complex with RPM1679 | monomer | 99.62 | 1×0BZ; 2×EDO; | |||
| Structure of Aurora kinase A complexed to pyrazole-aminoquinoline inhibitor III | monomer | 100.0 | 1×P9J; | |||
| Aurora A kinase domain with phthalazinone pyrazole inhibitor | monomer | 100.0 | 1×P9J; | |||
| Aurora A kinase in complex with TPX2-inhibitor 10 | monomer | 100.0 | 1×ADP; 2×MG; 1×T1L; 1×T5L; 5×SO4; 2×DMS; 1×ACT; | |||
| Aurora A kinase in complex with TPX2-inhibitor 2 | monomer | 100 | 2×MG; 1×T4X; 1×ADP; | |||
| Structure determination of Aurora Kinase in complex with inhibitor | monomer | 100.0 | 1×L0F; | |||
| Crystal Structure of Aurora-A in complex with a new Quinazoline inhibitor | monomer | 100.0 | 1×9A6; | |||
| The crystal structure of human AURKA kinase domain in complex with AURKA-compound 9 | monomer | 100.0 | 1×C0N; | |||
| Design, synthesis, and biological evaluation of pyrazolopyridine-sulfonamides as potent multiple-mi… | monomer | 100.0 | 1×D36; 1×MG; | |||
| The crystal structure of human aurka kinase domain in the complex with aurka-compound 25 | monomer | 100.0 | 1×C74; | |||
| Aurora A in complex with RPM1715 | monomer | 99.62 | 1×0C5; | |||
| Structure determination of Aurora Kinase in complex with inhibitor | monomer | 100.0 | 1×L0E; | |||
| The crystal structure of human aurka kinase domain in complex with AURKA-A2 | monomer | 100.0 | 1×E47; | |||
| Structure determination of Aurora Kinase in complex with inhibitor | monomer | 100.0 | 1×L0D; | |||
| Imidazo[1,2-a]pyrazine-based Aurora Kinase Inhibitors | monomer | 99.24 | 1×NRM; | |||
| Aurora A kinase bound to an imidazopyridine inhibitor (14d) | monomer | 100.0 | 1×7HD; | |||
| Crystal structure of anthranilamide 10 bound to AuroraA | monomer | 100.0 | 1×LJF; | |||
| Structure determination of Aurora Kinase in complex with inhibitor | monomer | 100 | 1×L0C; | |||
| Aurora-A bound to an inhibitor | monomer | 100.0 | 1×YM4; | |||
| Structure of Human Aurora A in Complex with a diaminopyrimidine | monomer | 99.6 | 1×E9Z; | |||
| Aurora A kinase in complex with TPX2-inhibitor 7 | monomer | 100.0 | 1×T3I; 1×ADP; 2×MG; 1×GOL; 1×T5L; 7×SO4; 2×DMS; 1×ACT; | |||
| Aurora A kinase in complex with TPX2-inhibitor 9 | monomer | 100.0 | 1×T2F; 1×ADP; 2×MG; 1×T5L; 6×SO4; 2×DMS; 1×ACT; | |||
| Aurora A kinase in complex with TPX2-inhibitor 8 | monomer | 100.0 | 1×T3U; 1×ADP; 2×MG; 1×T5L; 5×SO4; 2×DMS; 1×ACT; 2×CL; | |||
| Structural Basis for the Inhibition of Aurora A Kinase by a Novel Class of High Affinity Disubstitu… | monomer | 100.0 | 2×SO4; 1×CC3; | |||
| Aurora A kinase in complex with TPX2-inhibitor CAM2602 | monomer | 99.62 | 1×T4O; 1×ADP; 2×MG; 1×T5L; 5×SO4; 3×DMS; 1×ACT; | |||
| Structure of S155R Aurora-A somatic mutant | monomer | 99.58 | 3×ADP; | |||
| TPX2 residues 7-20 fused to Aurora A residues 116-389 dephosphorylated, and CoAlated on C290 | monomer | 100.0 | 1×COA; | |||
| Synthesis and SAR Studies of imidazo-[1,2-a]-pyrazine Aurora kinase inhibitors with improved off ta… | monomer | 100.0 | 1×0FY; | |||
| Structure of dephosphorylated Aurora A (122-403) bound to AMPPCP | monomer | 100.0 | 1×ACP; | |||
| Aurora A kinase in complex with TPX2-inhibitor 9 | monomer | 100 | 1×T0X; 1×MG; 1×ATP; | |||
| Structure of Aurora A mutant bound to Biogenidec cpd 15 | monomer | 100.0 | 1×0K6; 1×PO4; 1×MG; | |||
| Structure of Aurora-A bound to an imidazopyrazine inhibitor | monomer | 99.59 | 1×ASH; | |||
| Human Aurora A catalytic domain bound to FK932 | monomer | 100.0 | 1×4RM; 1×MPD; | |||
| Aurora A kinase bound to an imidazopyridine inhibitor (14b) | monomer | 100.0 | 1×6F2; | |||
| Human Aurora A catalytic domain bound to FK1141 | monomer | 100.0 | 1×4RJ; | |||
| Human Aurora A catalytic domain bound to FK1142 | monomer | 100.0 | 1×4RK; 1×MPD; | |||
| STRUCTURE OF AURORA A IN COMPLEX WITH MLN8054 | monomer | 100.0 | 1×ZZL; | |||
| Human Aurora A catalytic domain bound to SB-6-OH | monomer | 100.0 | 1×4QV; | |||
| Structure of Aurora-2 in complex with PHA-739358 | monomer | 100.0 | 1×627; 1×SO4; | |||
| Aurora A kinase bound to an imidazopyridine inhibitor (7a) | monomer | 100.0 | 1×5GX; 2×SO4; | |||
| SAR156497 an exquisitely selective inhibitor of Aurora kinases | monomer | 100.0 | 1×QMN; | |||
| Aurora-A Inhibitor Structure (2nd crystal form) | monomer | 98.83 | 1×ZZL; | |||
| Structure of Aurora kinase A complexed to benzoimidazole-indazole inhibitor XV | monomer | 100.0 | 1×N15; | |||
| Crystal structure of Aurora-A in complex with a pentacyclic inhibitor | monomer | 98.38 | 1×83H; | |||
| CRYSTAL STRUCTURE OF AURORA-2, AN ONCOGENIC SERINE-THREONINE KINASE | monomer | 100.0 | 1×ADN; | |||
| Aurora A in complex with a bisanilinopyrimidine | monomer | 100.0 | 1×45B; | |||
| Structure of unphosphorylated D274N mutant of Aurora-A | monomer | 99.59 | 1×ATP; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2j4z.2.A | monomer | 0.82 | 1×626; | 100.00 | ||